Epidemiological cohort study of systemic antifungal therapy for suspected or confirmed invasive candidiasis in the ICU: the Amarcand2 study

समान संसाधन

• Antifungal De-Escalation Is Safe in Critically Ill Patients Treated For Suspected Or Documented Invasive Candidiasis. Data From The Amarcand2 Study
  द्वारा: Bailly, S, और अन्य
  प्रकाशित: (2015)
• Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study
  द्वारा: Leroy, Olivier, और अन्य
  प्रकाशित: (2016)
• Clinical Impact of Antifungal Susceptibility, Biofilm Formation and Mannoside Expression of Candida Yeasts on the Outcome of Invasive Candidiasis in ICU: An Ancillary Study on the Prospective AmarCAND2 Cohort
  द्वारा: Gangneux, Jean-Pierre, और अन्य
  प्रकाशित: (2018)
• Clinical Impact of Antifungal Susceptibility, Biofilm Formation and Mannoside Expression of Candida Yeasts on the Outcome of Invasive Candidiasis in ICU: An Ancillary Study on the Prospective AmarCAND2 Cohort
  द्वारा: Jean-Pierre Gangneux, और अन्य
  प्रकाशित: (2018-12-01)
• Management of invasive candidiasis in nonneutropenic ICU patients
  द्वारा: Weiss, Emmanuel, और अन्य
  प्रकाशित: (2014)